Showing results (931-940 of 2,331) with videos related to
Sort By:
Pageof 234
Clinical Drug Investigation|October 3, 2013
Pharmacokinetic characterization of tizanidine nasal spray, a novel intranasal delivery method for the treatment of skeletal muscle spasmDaniela Cristina Vitale, Cateno Piazza, Tiziana Sinagra, et al.Clinical Drug Investigation|July 25, 2013
Fixed-dose ibuprofen/famotidine: a review of its use to reduce the risk of gastric and duodenal ulcers in patients requiring NSAID therapyEmma D DeeksClinical Drug Investigation|March 17, 2012
Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and childrenJesse DeLeon, Bruce E Silverstein, Catherine Allaire, et al.Clinical Drug Investigation|December 16, 2011
Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre studyHaiyan Li, Kathleen Butler, Li Yang, et al.Clinical Drug Investigation|January 7, 2015
An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysisAkio Arakawa, Masayuki Kaneko, Mamoru NarukawaClinical Drug Investigation|November 7, 2015
Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind StudiesEdward M Kerwin, Herminia Taveras, Harald Iverson, et al.Clinical Drug Investigation|November 27, 2013
Insulin degludec: pharmacokinetic properties in subjects with hepatic impairmentViera Kupčová, Gerhard Arold, Carsten Roepstorff, et al.Clinical Drug Investigation|August 23, 2014
Evaluation of the effect of multiple doses of lansoprazole on the pharmacokinetics and safety of ponatinib in healthy subjectsNarayana I Narasimhan, David J Dorer, Jeffrey Davis, et al.Clinical Drug Investigation|September 5, 2014
Population pharmacokinetics and dose-exposure proportionality of edoxaban in healthy volunteersOphelia Q P Yin, Raymond MillerClinical Drug Investigation|August 16, 2014
Glucose-lowering effect of insulin degludec is independent of subcutaneous injection regionLeszek Nosek, Hans-Veit Coester, Carsten Roepstorff, et al.Pageof 234